Results 51 to 60 of about 75,591 (303)

A conceptual framework for how structural changes in emerging acute substance use service models can reduce stigma of medications for opioid use disorder

Frontiers in Psychiatry, 2023
Stigma toward people taking medication for opioid use disorder (MOUD) is prevalent, harmful to the health and well-being of this population, and impedes MOUD treatment resource provision, help-seeking, and engagement in care.
Timothy D. Becker, Timothy D. Becker, Evan L. Eschliman, Ashish P. Thakrar, Lawrence H. Yang, Lawrence H. Yang   +5 more
doaj   +1 more source

Opioid use disorder and the brain: a clinical perspective.

, 2022
Opioid use disorder (OUD) has gained increasing publicity and interest during recent years, with many countries describing problems of epidemic proportions with regard to opioid use and deaths related to opioids.
Herlinger, Katherine, Lingford-Hughes, Anne   +1 more
core   +1 more source

Family member opioid prescriptions and opioid use disorder [PDF]

Addictive Behaviors, 2019
It is recognized that family members are a major source of diverted opioids. Yet it is not known how family member opioid prescriptions predict the development of an opioid use disorder (OUD).We conducted an observational study using commercial health care claims to investigate the association between a family member opioid prescription and an ...
Mir M. Ali, Rachel Mosher Henke, Ryan Mutter, Peggy L. O'Brien, Eli Cutler, Maryann Mazer-Amirshahi, Jesse M. Pines   +6 more
openaire   +2 more sources

Neighborhood Socioeconomic Status and Short‐Term Functional Outcomes in Systemic Lupus Erythematosus

Arthritis Care &Research, EarlyView.
Objective Individuals with systemic lupus erythematosus (SLE) can accumulate functional status (FS) impairment. We evaluated the association between neighborhood socioeconomic disadvantage, as measured by the Area Deprivation Index (ADI), and FS in a national SLE sample.
Baljeet Rai, Jessica Fitzpatrick, Jing Li, Eric Roberts, Patricia Katz, Laura Plantinga, Gabriela Schmajuk, Jinoos Yazdany   +7 more
wiley   +1 more source

The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State

Addiction Science & Clinical Practice, 2022
Background Opioid use disorder (OUD) is a serious health condition that is effectively treated with buprenorphine. However, only a minority of people with OUD are able to access buprenorphine.
Caleb J. Banta-Green, Mandy D. Owens, Jason R. Williams, Jeanne M. Sears, Anthony S. Floyd, Wendy Williams-Gilbert, Susan Kingston   +6 more
doaj   +1 more source

Integrating opioid use disorder treatment into primary care settings.

, 2023
Importance: Medication for opioid use disorder (MOUD) (eg, buprenorphine and naltrexone) can be offered in primary care, but barriers to implementation exist.
Heald, Ashley, Ratzliff, Anna D, Williams, Emily C, Saxon, Andrew J, Chen, Jessica, Merrill, Joseph O, Austin, Elizabeth J, Briggs, Elsa S, Curran, Geoffrey M, Ferro, Lori, Fortney, John C, Barry, Paul   +11 more
core   +1 more source

GPCRs in CAR‐T Cell Immunotherapy: Expanding the Target Landscape and Enhancing Therapeutic Efficacy

Advanced Science, EarlyView.
Chimeric antigen receptor T cell therapy faces dual challenges of target scarcity and an immunosuppressive microenvironment in solid tumors. This review highlights how G protein‐coupled receptors can serve as both novel targets to expand the therapeutic scope and functional modules to enhance CAR‐T cell efficacy.
Zhuoqun Liu, Yuchen Xiao, Yamin Zhao, Lihe Dai, David J.H. Shih, Shikang Liang, Honglei Tian, Liu Liu, Feng Tian, Bing Liu, Lei Chang, Chao Zhang   +11 more
wiley   +1 more source

The impact of stigma surrounding use of medications for opioid use disorder.

, 2020
Substance use disorders (SUDs) are highly stigmatized conditions, with stigma hindering and discouraging individuals from seeking treatment services. Not only does stigma exist for individuals with SUDs, but also for individuals who use medications to ...

core  

Medication-assisted treatment for opioid use disorder [PDF]

"The opioid overdose epidemic continues to claim lives across the country with a record 47,600 overdose deaths in 2017. (This number represents 67.8% of the 70,237 overdose deaths from all drugs) [CDC 2018a].

core   +1 more source

The divided dose approach to perioperative buprenorphine -management in patients with opioid use disorder.

, 2021
Click on the Resource Link to access the article (may not be free).There is limited evidence and no clear consensus suggesting best practices for perioperative buprenorphine management in patients with opioid use disorder.
Engle, Amanda L, Winans, Amanda R M, Demma, Linda, Cleary, Jacqueline H.   +3 more
core   +1 more source